|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 35/76 | |
| A61N 5/00 | |||
| A61P 35/00 |
| (11) | Number of the document | 1984007 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07701775.4 |
| Date of filing the European patent application | 2007-02-09 | |
| (97) | Date of publication of the European application | 2008-10-29 |
| (45) | Date of publication and mention of the grant of the patent | 2015-08-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CA2007/000187 |
| Date | 2007-02-09 |
| (87) | Number | WO 2007/093036 |
| Date | 2007-08-23 |
| (30) | Number | Date | Country code |
| 773068 P | 2006-02-13 | US | |
| 788898 P | 2006-04-03 | US |
| (72) |
COFFEY, Matthew, C., CA
THOMPSON, Bradley, G., CA
|
| (73) |
Oncolytics Biotech Inc.,
Suite 210 1167 Kensington Crescent N. W., Calgary, AB T2N 1X7,
CA
|
| (54) | USE OF LOW DOSE LOCAL IMMUNE SUPPRESSION TO ENHANCE ONCOLYTIC VIRAL THERAPY |
| USE OF LOW DOSE LOCAL IMMUNE SUPPRESSION TO ENHANCE ONCOLYTIC VIRAL THERAPY |